Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Human Pathology|May 1, 1995
Expression of muscle actins in diffuse mesotheliomasI T Kung, V Thallas, E J Spencer, et al.
Diabetologia|June 16, 2000
The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulationM E Cooper, V Thallas, J Forbes, et al.
Diabetologia|February 12, 1998
Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic ratsT Soulis, M E Cooper, S Sastra, et al.
Diabetologia|June 1, 1997
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injuryT Soulis, V Thallas, S Youssef, et al.
Diabetologia|February 24, 2006
A developmental nephron deficit in rats is associated with increased susceptibility to a secondary renal injury due to advanced glycation end-productsM A Zimanyi, K M Denton, J M Forbes, et al.
Diabetologia|February 24, 2001
Renoprotective effects of a novel inhibitor of advanced glycationJ M Forbes, T Soulis, V Thallas, et al.
The Journal of Clinical Investigation|December 19, 2001
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)M D Oldfield, L A Bach, J M Forbes, et al.
Diabetologia|May 7, 1999
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetesT Soulis, S Sastra, V Thallas, et al.
Pageof 1